Immune to Cancer: The CRI Blog
-
Supercharging T Cells to Fight Cancer: A Revolutionary Discovery
In the battle against cancer, our immune system’s T cells are frontline soldiers, designed to seek out… -
ASCO 2022 Recap: Cancer Immunotherapy Updates
Since the first FDA approval in 2011 to treat cancer patients with checkpoint immunotherapy, doctors have sought… -
Melanoma Monday: 2022 Immunotherapy Research Updates
This Melanoma Monday, discover new research, new treatments, and progress for a future immune to melanoma.
-
FDA Approves New LAG-3 Checkpoint Inhibitor Immunotherapy Combination
Patients with unresectable or metastatic melanoma can now be treated with dual checkpoint blockade targeting the PD-1…
-
Melanoma Monday: 2021 Immunotherapy Research Updates
Today for Melanoma Monday, we look at new research, new treatments, and how we’re working toward a…
-
Marguerite Sullivan’s Immunotherapy Story
Melanoma | Diagnosed 2012 I truly feel I’m here because of immunotherapy. Marguerite’s Story For Marguerite Sullivan, 63,… -
Melanoma Monday: 2020 Immunotherapy Research Update
Bringing immunotherapy earlier into treatment, extraordinary patient journeys, and how we’re working toward a future immune to…
-
Melanoma and Immunotherapy: Tara’s Journey to Become a Cancer Patient Advocate
Melanoma veteran Tara Ryan shares her experience with taking control of her health, resilience in the face…
-
Isolde Arzt’s Immunotherapy Story: Raising Awareness of Melanoma in Mexico
Melanoma survivor Isolde Arzt shares her path from cancer patient to patient advocate in Mexico.